Learn more

SHIRE CANADA INC

Overview
  • Total Patents
    49
About

SHIRE CANADA INC has a total of 49 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Australia, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BIOTA SCIENT MANAGEMENT, SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO LTD and PLUS CHEMICALS S A.

Patent filings per year

Chart showing SHIRE CANADA INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Simion Dan 10
#2 Cimpoia Alex 9
#3 Vizitiu Dragos 8
#4 Lacoste Jean-Eric 7
#5 Dan Simion 4
#6 Giles Francis J 3
#7 Alex Cimpoia 3
#8 Yu Qing 3
#9 Couch Richard A 2
#10 Michaels Alex 2

Latest patents

Publication Filing date Title
JP2012136526A METHOD FOR PRODUCING OPTICALLY ACTIVE cis-2-HYDROXYMETHYL-4-(CYTOSINE-1'-YL)-1,3-OXATHIOLANE OR PHARMACEUTICALLY PERMISSIBLE SALT THEREOF
NZ591709A Enantiomeric resolution of 2,4-disubstituted 1,3-oxathiolane nucleosides by conglomerate resolution
MY146568A Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
ZA200707518B Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3-Oxathiolane or pharmaceutically acceptable salts thereof
AU2005329355A1 Process and methods for the preparation of optically active cis-2-Hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts
US2006199786A1 Process and methods for the preparation of optically active cis-2-hydroxymethyl-4- (cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
AU2002344862B2 Stereoselective method for the preparation of nucleoside analogues